Invesco Ltd. - VALEANT PHARMACEUTICALS INTL ownership

VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 510 filers reported holding VALEANT PHARMACEUTICALS INTL in Q4 2014. The put-call ratio across all filers is 1.37 and the average weighting 1.2%.

Quarter-by-quarter ownership
Invesco Ltd. ownership history of VALEANT PHARMACEUTICALS INTL
ValueSharesWeighting
Q2 2018$19,204,000
+13.6%
826,315
-22.2%
0.01%0.0%
Q1 2018$16,911,000
-33.2%
1,062,257
-12.9%
0.01%
-33.3%
Q4 2017$25,334,000
+23.3%
1,219,163
-15.0%
0.01%
+12.5%
Q3 2017$20,549,000
-30.3%
1,433,921
-15.9%
0.01%
-11.1%
Q2 2017$29,499,000
+26.5%
1,705,131
-19.3%
0.01%
+12.5%
Q1 2017$23,313,000
+2649.2%
2,113,542
+3516.3%
0.01%
Q4 2016$848,000
-49.0%
58,445
-13.8%
0.00%
-100.0%
Q3 2016$1,664,000
+15.9%
67,779
-4.9%
0.00%0.0%
Q2 2016$1,436,000
-29.5%
71,293
-8.1%
0.00%0.0%
Q1 2016$2,038,000
-80.4%
77,545
-24.1%
0.00%
-75.0%
Q4 2015$10,385,000
-42.5%
102,158
+0.9%
0.00%
-50.0%
Q3 2015$18,063,000
-37.8%
101,270
-22.5%
0.01%
-27.3%
Q2 2015$29,030,000
+4.2%
130,687
-7.3%
0.01%0.0%
Q1 2015$27,858,000
+14.6%
140,973
-17.0%
0.01%
+22.2%
Q4 2014$24,302,000
+59.3%
169,802
+46.1%
0.01%
+50.0%
Q3 2014$15,253,000
+2.7%
116,188
-1.0%
0.01%0.0%
Q2 2014$14,859,000
-52.4%
117,364
-50.4%
0.01%
-53.8%
Q1 2014$31,207,000
-14.9%
236,801
-24.3%
0.01%
-13.3%
Q4 2013$36,679,000
-0.8%
312,706
-11.6%
0.02%
-6.2%
Q3 2013$36,958,000
+4.6%
353,932
-13.8%
0.02%0.0%
Q2 2013$35,317,000410,5360.02%
Other shareholders
VALEANT PHARMACEUTICALS INTL shareholders Q4 2014
NameSharesValueWeighting ↓
Brave Warrior Advisors 6,050,442$763,082,00030.78%
LeVasseur Capital Partners LLC 190,404$24,014,00029.50%
FARLEY CAPITAL L.P. 333,081$42,008,00027.09%
Ruane, Cunniff & Goldfarb 34,298,384$4,325,712,00023.07%
ValueAct Holdings 18,923,877$2,386,679,00017.64%
Tesuji Partners 1,368,040$172,537,00017.22%
Brahman Capital Corp. 3,902,877$492,231,00013.63%
Arrow Capital Management, LLC 197,500$24,909,00013.60%
Hound Partners 2,851,175$359,590,00013.45%
Ratan Capital Management LP 731,960$92,315,00013.09%
View complete list of VALEANT PHARMACEUTICALS INTL shareholders